Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features
Jennifer M. Coughlin, Lindsay N. Hayes, Teppei Tanaka, et al.
Schizophrenia Research (2016) Vol. 183, pp. 64-69
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
Tina Notter, Jennifer M. Coughlin, Akira Sawa, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 1, pp. 36-47
Closed Access | Times Cited: 136
Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis
Juan A. Gallego, Emily A. Blanco, Sehba Husain-Krautter, et al.
Schizophrenia Research (2018) Vol. 202, pp. 64-71
Open Access | Times Cited: 102
Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry
Leslie G. Nucifora, Tetsu Tanaka, Lindsay N. Hayes, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 8, pp. e1215-e1215
Open Access | Times Cited: 77
Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study
Thomas W. Sedlak, Leslie G. Nucifora, Minori Koga, et al.
Complex Psychiatry (2017) Vol. 3, Iss. 4, pp. 214-222
Open Access | Times Cited: 74
Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia
Mei Hong Xiu, Zezhi Li, Da Chun Chen, et al.
Schizophrenia Bulletin (2020) Vol. 46, Iss. 6, pp. 1498-1510
Open Access | Times Cited: 51
Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis
Troels Boldt Rømer, Rose Jeppesen, Rune Haubo Bojesen Christensen, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2277-2290
Closed Access | Times Cited: 20
Identification of a miRNAs signature associated with exposure to stress early in life and enhanced vulnerability for schizophrenia: New insights for the key role of miR-125b-1-3p in neurodevelopmental processes
Nadia Cattane, Cristina Mora, Nicola Lopizzo, et al.
Schizophrenia Research (2018) Vol. 205, pp. 63-75
Open Access | Times Cited: 51
Association of acute psychosocial stress with oxidative stress: Evidence from serum analysis
Eunkyoung Kim, Zhiling Zhao, John R. Rzasa, et al.
Redox Biology (2021) Vol. 47, pp. 102138-102138
Open Access | Times Cited: 37
Cognitive functions associated with developing prefrontal cortex during adolescence and developmental neuropsychiatric disorders
Takeshi Sakurai, Nao J. Gamo
Neurobiology of Disease (2018) Vol. 131, pp. 104322-104322
Closed Access | Times Cited: 42
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Emily G. Severance, Faith Dickerson, Robert H. Yolken
Pharmacology & Therapeutics (2018) Vol. 189, pp. 184-198
Open Access | Times Cited: 41
Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition
Caroline F. Zink, Peter B. Barker, Akira Sawa, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 12, pp. 1129-1139
Closed Access | Times Cited: 35
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
Yi‐Ling Chien, Hai‐Gwo Hwu, Tzung‐Jeng Hwang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 99, pp. 109868-109868
Closed Access | Times Cited: 34
Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients
Patrick Buosi, Fábio Aparecido Borghi, Angélica Marta Lopes, et al.
Trends in Psychiatry and Psychotherapy (2021)
Open Access | Times Cited: 28
Oxidative Stress and Emergence of Psychosis
Victoria Rambaud, Aude Marzo, Boris Chaumette
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1870-1870
Open Access | Times Cited: 20
Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis
Vanessa Cropley, M. Kittel, Meike Heurich, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 136-144
Open Access | Times Cited: 11
A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function
Mei-Fang Xiao, Seung‐Eon Roh, Jiechao Zhou, et al.
Science Advances (2021) Vol. 7, Iss. 48
Open Access | Times Cited: 27
Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing?
Zarrin Ansari, Sudhir Pawar, Rajmohan Seetharaman
Postgraduate Medicine (2021) Vol. 134, Iss. 2, pp. 187-199
Closed Access | Times Cited: 24
Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
Wenxi Sun, Ping Sun, Jin Li, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Nuclear GAPDH in cortical microglia mediates cellular stress-induced cognitive inflexibility
Adriana Ramos, Koko Ishizuka, Arisa Hayashida, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 10, pp. 2967-2978
Open Access | Times Cited: 3
Digging deeper in the proteome of different regions from schizophrenia brains
Guilherme Reis‐de‐Oliveira, Giuliana S. Zuccoli, Mariana Fioramonte, et al.
Journal of Proteomics (2020) Vol. 223, pp. 103814-103814
Closed Access | Times Cited: 22
Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study
Xirong Li, Mei Hong Xiu, Xiao Guan, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 1316-1324
Open Access | Times Cited: 20
Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia
Zhi Wei Wu, Hong Yu, Xuan Wang, et al.
Psychosomatic Medicine (2021) Vol. 83, Iss. 5, pp. 485-491
Closed Access | Times Cited: 19
Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study
Maiara Zeni‐Graiff, Adiel C. Rios, Pawan Kumar Maurya, et al.
CNS Spectrums (2017) Vol. 24, Iss. 03, pp. 333-337
Closed Access | Times Cited: 18
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study
Haixia Liu, Hua Liu, Shuling Jiang, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1793-1803
Open Access | Times Cited: 13
Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia
Dongmei Wang, Da Chun Chen, Li Wang, et al.
The World Journal of Biological Psychiatry (2020) Vol. 22, Iss. 5, pp. 325-334
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top